NASDAQ:IMA | Free Cash Flow | ImageneBio, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$14.8M
2025-12-31-$7.22M
2025-03-31-$7.23M
2024-12-31-$3.48M
2024-03-31-$18.3M
2023-12-31-$21.82M$262,000.00-$22.08M
2023-03-31-$19.78M$152,000.00-$19.94M
2022-12-31-$17.66M$231,000.00-$17.89M
2022-03-31-$19.78M$33,000.00-$19.82M
2021-12-31-$13.37M$550,000.00-$13.92M-497.60%
2021-03-31-$13.17M$839,000.00-$14.01M
2020-12-31-$12.57M$650,000.00-$13.22M
2020-03-31-$9.87M$117,000.00-$9.99M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$47.84M
2024-12-31-$21.32M
2023-12-31-$79.74M$414,000.00-$80.16M
2022-12-31-$74.11M$1.43M-$75.54M
2021-12-31-$60.25M$1.76M-$62.01M
2020-12-31-$37.83M$766,000.00-$38.59M